Our observation that in CML patients in DMR previously exposed to IFNα NK cells are not increased in percentage but are more active suggests that IFNα stimulates the host immune compartment against residual disease. This evidence concerns the gene IFNA1 and chronic myelogenous leukemia, BCR-ABL1 positive.